WallStreetZenWallStreetZen

NASDAQ: PYXS
Pyxis Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PYXS

Based on 2 analysts offering 12 month price targets for Pyxis Oncology Inc

Min Forecast
$5.00+316.67%
Avg Forecast
$6.50+441.67%
Max Forecast
$8.00+566.67%

Should I buy or sell PYXS stock?

Based on 2 analysts offering ratings for Pyxis Oncology Inc.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PYXS's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates PYXS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their PYXS stock forecasts and price targets.

PYXS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-19
lockedlocked$00.00+00.00%2025-03-19

1 of 1

Forecast return on equity

Is PYXS forecast to generate an efficient return?

Company
-55.47%
Industry
140.91%
Market
90.47%
PYXS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PYXS forecast to generate an efficient return on assets?

Company
-42.1%
Industry
32.45%
PYXS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PYXS earnings per share forecast

What is PYXS's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.38
Avg 2 year Forecast
-$1.28
Avg 3 year Forecast
-$1.25

PYXS revenue forecast

What is PYXS's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$12.0M
Avg 2 year Forecast
$73.0M
Avg 3 year Forecast
$82.1M

PYXS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PYXS$1.20$6.50+441.67%Buy
ZURA$1.20$11.25+837.50%Strong Buy
EPIX$1.67N/AN/A
INO$2.00$9.75+387.50%Buy
IGMS$1.21$1.80+48.76%Hold
View Top Biotech Stocks

Pyxis Oncology Stock Forecast FAQ

Is Pyxis Oncology Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PYXS) stock is to Buy PYXS stock.

Out of 2 analysts, 0 (0%) are recommending PYXS as a Strong Buy, 2 (100%) are recommending PYXS as a Buy, 0 (0%) are recommending PYXS as a Hold, 0 (0%) are recommending PYXS as a Sell, and 0 (0%) are recommending PYXS as a Strong Sell.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.

What is PYXS's earnings growth forecast for 2025-2027?

(NASDAQ: PYXS) Pyxis Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Pyxis Oncology's earnings in 2025 is -$95,233,000.On average, 5 Wall Street analysts forecast PYXS's earnings for 2025 to be -$85,239,987, with the lowest PYXS earnings forecast at -$96,018,881, and the highest PYXS earnings forecast at -$76,815,105. On average, 5 Wall Street analysts forecast PYXS's earnings for 2026 to be -$79,169,116, with the lowest PYXS earnings forecast at -$90,443,591, and the highest PYXS earnings forecast at -$60,708,712.

In 2027, PYXS is forecast to generate -$77,434,581 in earnings, with the lowest earnings forecast at -$84,248,824 and the highest earnings forecast at -$71,239,815.

What is PYXS's revenue growth forecast for 2027-2029?

(NASDAQ: PYXS) Pyxis Oncology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Pyxis Oncology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PYXS's revenue for 2027 to be $743,371,980, with the lowest PYXS revenue forecast at $743,371,980, and the highest PYXS revenue forecast at $743,371,980. On average, 1 Wall Street analysts forecast PYXS's revenue for 2028 to be $4,522,179,545, with the lowest PYXS revenue forecast at $4,522,179,545, and the highest PYXS revenue forecast at $4,522,179,545.

In 2029, PYXS is forecast to generate $5,085,283,820 in revenue, with the lowest revenue forecast at $476,997,021 and the highest revenue forecast at $12,071,741,479.

What is PYXS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PYXS) forecast ROA is -42.1%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is PYXS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PYXS price target, the average PYXS price target is $6.50, with the highest PYXS stock price forecast at $8.00 and the lowest PYXS stock price forecast at $5.00.

On average, Wall Street analysts predict that Pyxis Oncology's share price could reach $6.50 by May 19, 2026. The average Pyxis Oncology stock price prediction forecasts a potential upside of 441.67% from the current PYXS share price of $1.20.

What is PYXS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PYXS) Pyxis Oncology's current Earnings Per Share (EPS) is -$1.58. On average, analysts forecast that PYXS's EPS will be -$1.38 for 2025, with the lowest EPS forecast at -$1.55, and the highest EPS forecast at -$1.24. On average, analysts forecast that PYXS's EPS will be -$1.28 for 2026, with the lowest EPS forecast at -$1.46, and the highest EPS forecast at -$0.98. In 2027, PYXS's EPS is forecast to hit -$1.25 (min: -$1.36, max: -$1.15).

What is PYXS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PYXS) forecast ROE is -55.47%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.